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ABSTRACT
Purpose Phacoemulsification has been shown to 
reduce intraocular pressure (IOP). The mechanism of 
action is thought to be via increased trabecular outflow 
facility. However, studies on the relationship between 
phacoemulsification and outflow facility have been 
inconsistent. This study intended to examine the change 
in electronic Schiotz tonographic outflow facility (TOF) 
and IOP measurements following phacoemulsification.
Methods Patients who were due to undergo a 
standard clear corneal incision phacoemulsification 
with intraocular lens (IOL) implantation, at St Thomas’ 
Hospital, were invited to participate in this study. IOP 
was measured using Goldmann’s applanation tonometer, 
and TOF was measured by electronic Schiotz tonography 
at baseline and at 3, 6 and 12 months postoperatively.
Results Forty-one patients were recruited. Tonography 
data for 27 patients were reliable and available 
at all time points. Eleven cases had primary open 
angle glaucoma and cataract, while 16 patients had 
cataract only. Mean IOP reduced at every time point 
postoperatively significantly compared with baseline. 
TOF improved significantly after cataract extraction at 
all time points (baseline of 0.14±0.06 vs 0.18±0.09 at 
3 months, P=0.02 and 0.20±0.09 at 6 months, P=0.003, 
0.17±0.07 µL/min mmHg at 12 months, P=0.04). Five 
contralateral eyes of patients with cataracts only who did 
not have any intraocular surgery during the follow-up 
period were used as comparison. Their IOP and TOF did 
not change significantly at any postoperative visits.
Conclusion This is the first study using electronic 
Schiotz tonography with documented anterior chamber 
depth and gonioscopy after modern cataract surgery 
(CS) with phacoemulsification and IOL implantation. We 
demonstrated that phacoemulsification increases TOF 
and this fully accounts for the IOP reduction following 
CS.
ISTCRN registration number ISRCTN04247738.
INTRODUCTION
Several studies explored the effects of phacoemul-
sification on intraocular pressure (IOP) changes at 
short (6 months), medium (36 months) and long 
term (60 months).1–5 The reported IOP reduction 
varies between 1.5 and 9.0 mm Hg.5–7 Different 
mechanisms of action have been proposed for 
the IOP-lowering effects following cataract 
surgery (CS), including the mechanical influence 
of the lens removal,6 increased uveoscleral outflow 
and increased trabecular outflow.8 However, there 
are no studies using electronic Schiotz tonog-
raphy assessing the effect of modern small incision 
phacoemulsification with intraocular lens (IOL) 
implantation on trabecular outflow facility.
Lee and Trotter9 investigated the effect of extra-
capsular cataract extraction without IOL implanta-
tion on the facility of outflow. They used electronic 
Schiotz tonography in patients with cataract of 
whom seven cases had open or closed angle glau-
coma and 11 cases of pseudoexfoliation. They 
showed that facility of outflow decreased within 
first 3 weeks postoperatively but then returned 
to preoperative values within 4 months after the 
operation. However, in this study, outflow facility 
changes were very variable. Additionally, they had 
included mixed cases of complicated surgeries 
such as vitreous loss and the follow-up was only 6 
months.
Another study by Meyer and associates,10 
demonstrated that pneumatonographic outflow 
facility after phacoemulsification improved on the 
first day after surgery; however, outflow facility at 
1 year (0.46±0.38 µL/min mm Hg) was not statis-
tically different compared with the baseline of 
0.39±0.23 µL/min mm Hg.
To date, there have been no studies using elec-
tronic Schiotz tonography (which is a method of 
outflow facility measurement with less intersub-
ject and interobserver variability compared with 
pneumatonography11–13) to determine the effect of 
modern small incision phacoemulsification CS on 
tonographic facility of outflow.
METHODS
This research conformed to the tenets of the 
Declaration of Helsinki. Patients with visually 
significant cataract with or without primary open 
angle glaucoma (POAG), who were due to undergo 
phacoemulsification with IOL implantation, were 
enrolled in this prospective study. The recruitment 
took place between September 2009 and May 
2011. POAG was defined as IOP >21 mmHg on 
at least one occasion and abnormal visual field 
testing with corresponding optic disc changes. 
Only one eye per patient was included in the final 
analysis. When both eyes were eligible, only the 
first eye to be operated on was included in the 
analysis. Patients were provided with study infor-
mation at the initial contact, and signed informed 
consent was sought before measurements and the 
surgery. Patients with any history of intraocular or 
keratorefractive surgery, any secondary glaucoma 
including traumatic, neovascular, uveitic, pseudo-
exfoliative and pigment dispersion syndrome were 
excluded.
Contralateral eyes of the study patients, which 
did not undergo any intraocular surgery during 
the follow-up period, with available tonographic 
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outflow facility (TOF) and IOP data at all time points postoper-
atively, were used for the comparison purposes.
Measurements
All patients underwent a comprehensive ophthalmic exam-
ination before the operation, including visual acuity measure-
ment (LogMAR), slit lamp biomicroscopy, gonioscopy, IOP 
measurement using Goldmann’s applanation tonometer, ante-
rior chamber depth (ACD) and axial length (AXL) measurement 
using IOL Master (Carl Zeiss Meditec, Dublin, California, USA), 
central corneal thickness (CCT; Pachmate DGH 55, DGH Tech-
nology, Exton, Pennsylvania, USA), static automated visual field 
(Humphrey automated white-on white, 24–2 SITA-standard; 
Carl Zeiss Meditec), and dilated ophthalmoscopic examination.
TOF (TOF=‘C’) was measured with an electronic Schiotz 
tonographer (model 720; Berkeley Bioengineering, San 
Leandro, California, USA) on the day of the surgery (between 
09:00 and 11:00) prior to the operation and then repeated at 
3, 6 and 12 months postoperatively. The facility of outflow was 
measured from the rate of the decay of IOP in the supine posi-
tion during application of a recording Schiotz tonometer probe 
on the cornea, over a period of 4 min with a standard 5.5 g 
weight.12 Nine readings at 30 s intervals were manually entered 
the McLaren tonography computer program.11 The programme 
fits a second-degree polynomial by the method of least squares 
to nine data points and determines by extrapolation, the best-fit 
values at time 0 and 4 min. The values at 0 and 4 min are then 
used to calculate ‘C’ based on standard nomograms.12 14
Data collection and outcome measures
Data including age, gender, race, IOP, TOF, CCT, AXL, anterior 
chamber depth, gonioscopy, vertical cup: disc ratio and mean 
deviation in visual field testing were recorded.
Primary outcome measures were TOF (C) and IOP at 3, 6 and 
12 months’ postcataract extraction.
Surgical procedure
CS was performed by an experienced surgeon (KSL) under local 
or general anaesthesia. A clear corneal incision (2.8 mm) was 
made and followed by a paracentesis and the injection of visco-
elastic. Then capsulorrhexis and hydrodissection was performed. 
The lens was removed by phacoemulsification of the lens nucleus 
and aspiration of the cortical lens matter. After further injection 
of the viscoelastic, an acrylic injectable IOL (AcrySof SA60AT, 
Alcon, Texas, USA) of the appropriate power was inserted into 
the capsular bag. The viscoelastic was washed out and an intraca-
meral antibiotic injection was given at the end. Patients received 
Maxitrol (Neomycin sulfate 3500 IU/mL, Polymyxin B sulfate 
6000 IU/mL and 1 mg dexamethasone, Alcon Laboratories, UK) 
four times daily for 2 weeks and then twice daily for another 
2 weeks postoperatively. All patients were off steroid treatment 
after this period.
Sample size calculation
The SD of outflow facility was derived from a previous study by 
one of the authors.11 This study had a 90% chance of finding 
an 8.4% difference in outflow facility and 5% difference in IOP 
among two groups, if these differences existed (n=25 subjects, 
α=0.05 and β=0.10). There was no difference between the two 
groups in terms of relative changes in facility; therefore, we used 
combined data into one group of 25.
Statistical analysis
Student’s t-test and one-way analysis of variance (ANOVA) for 
repeated measures were used to compare continuous variables 
among groups. The 95% CIs for the mean difference between 
pairs for each outcome measure were calculated. Linear regres-
sion analysis was used to determine the correlation between IOP, 
facility of outflow and differences from baseline. P<0.05 was 
considered to be significant (IBM SPSS V.23.0).
RESULTS
Forty-one patients were enrolled in the study. Eight patients 
withdrew after signing the consent, due to their time constraints 
and inability to attend all required postoperative visits. Three 
subjects had poor tonography tracings on at least one time point 
(10% rejection rate in aqueous humour dynamic measurement 
is similar to previous studies).11 One case was excluded due 
to an intraoperative complication (posterior capsular rupture 
and vitreous loss) and two further cases were omitted due to 
persistent postoperative uveitis. In total, data from 27 patients 
with reliable tonographic outflow tracings at baseline and all 
subsequent study visits were included in the final analysis. Only 
one eye from each patient was used for the analysis.
Sixteen individuals had cataract only, while 11 cases had an 
existing diagnosis of POAG. The average age was comparable 
(in cataract cases mean age was 67±11.2 years, while in POAG 
group it was 73±7.2 years, P=0.09). Other baseline characteris-
tics of each group is shown in table 1.
Baseline IOP was similar in each group (15.7±2.7 mm Hg 
in non-glaucomatous cases vs 16.3±4.8 mm Hg in POAG with 
cataract group, P=0.7, 95% CI −3.6 to 2.4).
Overall, IOP reduced by 2.0±3.2 mm Hg at 3 months (12% 
decrease), while at 6-month and 12-month visits, it only reduced 
by 1.7±3.4 (10% decrease) and 2.0±3.6 mm Hg (10% decrease), 
respectively (table 2 and figure 1). We used one-way ANOVA for 
repeated measures to compare IOP between each visit. The IOP 
reduction at all post-operative visits was statistically significant 
(3 months P=0.003, 6 months P=0.04 and 12 months P=0.02).
TOF improved significantly at all postoperative time points 
after cataract extraction compared with the baseline (table 3 and 
figure 2). However, TOF enhancement did not differ between 
each visit using one-way ANOVA for repeated measures (at 3 
months P=0.7, at 6 months P=0.4 and at 12 months P=0.2). 
There was no statistically significant correlation between phaco 
power and TOF at any time point (at 3 months P=0.5, at 6 
months P=0.4 and at 12 months P=0.7).
The average postoperative IOP in cataract and POAG cases are 
shown in table 2 and figure 3. Mean IOP in cataract cases at 12 
months’ postsurgery was 13.7±3.0 mm Hg; this was comparable 
to POAG cases in which IOP decreased to 14.2±3.7 mm Hg 
(P=0.7, 95% CI −3.0 to 2.2). Overall, baseline IOP was a 
moderate predictor of postoperative IOP reduction at all time 
points (P=0.004, R=0.53).
Additionally, there was no statistically significant correlation 
between TOF changes and IOP alterations at any time point 
(P=0.08, r2=0.1) (figure 4). Furthermore, there was no statis-
tically significant correlation between AXL and ACD with IOP 
and TOF (P=0.9, r2=0.002).
The number of glaucoma medications and treatment regime 
remained unchanged in the POAG group at baseline and at 
all postoperative visits. All patients were on prostaglandin 
analogues. Additionally, five patients were taking beta blockers, 
four patients carbonic anhydrase inhibitor and one patient was 
on alpha-2 agonist medications. IOP and TOF measurements 
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were not statistically different in any particular group of these 
patients (P=0.35).
The IOP reduction was statistically significant at all postopera-
tive visits in cataract groups but not in the POAG group (table 2 
and figure 3).
While TOF in cataract group only improved at 3 and 6 
months postoperatively, in the glaucoma group only month 6 
TOF enhancement was statistically significant.
The comparative data is presented in figure 5.
Overall, baseline TOF was weakly correlated to TOF at 
3 month postoperatively (P=0.05, r=0.40) (figure 6).
We identified five patients (with cataract) who did not undergo 
any intraocular surgery in their contralateral eyes during the 
follow-up period and used their data as comparison. The average 
age of this group was 64.4±7.4 years. They all had open angles 
on gonioscopy (Shaffer’s grading of 3 or 4 in all quadrants) with 
mean anterior chamber depth of 2.98±0.62 mm. The baseline 
IOP for this group was 18.0±2.09 mm Hg, which did not change 
significantly at 3, 6 and 12 months’ visits (15.2±1.90 mm Hg 
at 3 months, P=0.84, 16.4±2.07 mm Hg, P=0.21 and 
16.8±2.71 mm Hg at 12 months, P=0.29) (figure 7). Simi-
larly, the facility of outflow at 3, 6 and 12 months compared 
with baseline was not statistically different at any time point 
(0.18±0.08 vs 0.18±0.09 at 3 months, P=0.1, 0.18±0.09 at 6 
months, P=0.55 and 0.18±0.07 µL/min mm Hg at 12 months, 
P=0.6) (figure 8).
DISCUSSION
This is the first study to assess the facility of tonographic outflow 
after modern small incision phacoemulsification with IOL 
implantation using electronic Schiotz tonography. We demon-
strated that IOP was significantly reduced at 3, 6 and 12 months 
after CS. In this study, the overall mean IOP reduction varied 
between 10% and 12%. There were also corresponding positive 
enhancement of TOF at all time points.
Numerous studies have explored the effect of phacoemulsi-
fication CS on IOP; all demonstrated significant but variable 
fall in IOP (1.5–9.0 mm Hg) postoperatively.4 6 15–19 However, 
current evidence is very limited on the effect of phacoemulsifica-
tion on the facility of outflow.
In the Ocular Hypertension Treatment Study (OHTS), the 
IOP reduction was 4.0 mm Hg, 3 years after CS,5 which was 
greater than observed IOP reduction in our study at 12 months 
(2.0±3.6 mm Hg). However, in the OHTS, baseline IOP was 
slightly higher (19.8±3.2 mm Hg) compared with our cohort 
(16.0±3.7 mm Hg). The IOP reduction after phacoemulsifica-
tion has been shown to be proportional to the preoperative IOP, 
with significantly greater IOP reduction observed among those 
Table 1 Baseline characteristics
Cataract only (n=16) POAG and cataract (n=11) P value 95% CI Overall (n=27)
Age (years)†, range 67±11.2 (43–82) 73±7.2 (59–83) 0.09 −14.8 to 1.1 69±10.2 (43–83)
Gender (F:M) 9:7 3:8 0.4 – 12:15
BCVA 0.3±0.4 0.3±0.2 0.7 −0.2 to 0.3 0.3±0.3
Ethnicity (Asian:Black:White) 0:4:12 2:6:3 0.5 – 2:10:15
ACD (mm)†, range 3.25±0.36 (2.9–3.8) 3.22±0.48 (2.85–4.1) 0.8 −0.3 to 0.3 3.23±0.40 (2.85–4.1)
AXL (mm)†, range 23.3±0.8 (22.8–24.5) 23.9±0.94 (22.5–25.7) 0.06 −1.3 to 0.05 23.6±0.89 (22.5–25.7)
CCT (µm)†, range 535±27 (497–596) 543±27 (507–580) 0.5 −29.4 to 14.1 538±26 (497–596)
IOP (mm Hg), range 15.7±2.8 (10–22) 16.3±4.8 (10–26) 0.7 −3.50 to 2.4 15.9±3.66 (10–26)
TOF (µL/min/mm Hg), range 0.15±0.06 (0.06–0.29) 0.13±0.08 (0.04–0.29) 0.4 −0.03 to 0.08 0.14±0.06 (0.04–0.29)
HVF (mean deviation)‡, range 2.5±0.6 (1.0–3.0) −11.7±1.9 (−14.0 to2.0) <0.001* – −3.1±8.84 (−14 to 3)
Cup disc ratio‡ 0.3 (0.2–0.7) 0.6 (0.6–0.9) <0.001* – 0.5 (0.2–0.9)
Phaco power, %, range 19.8±8.7 (10–31) 15.9±5.0 (10–27.9) 0.06 −2.1 to 9.9 18.2±7.5 (10–31)
Phaco time, minutes, range 2.25±4.12 (1.0–3.4) 1.54±0.54 (0.5–2.3) 0.16 −1.8 to 3.3 1.9±3.13 (0.5–3.4)
*Statistically significant.
†Student’s t-test (two sided).
‡Mann-Whitney test.
ACD, anterior chamber depth; AXL, axial length; BCVA, best corrected visual acuity; CCT, central corneal thickness; HVF, Humphrey visual field; IOP, intraocular pressure; POAG, 
primary open angle glaucoma.
Table 2 This table illustrates IOP reduction at postoperative visits at 3, 6 and 12 months compared with baseline IOP
IOP at 
baseline
IOP at 3 m 
(mm Hg), % of 
reduction
Comparison made 
to baseline
IOP at 6 m 
(mm Hg), % of 
reduction
Comparison made 
to baseline
IOP at 12 m 
(mm Hg), % of 
reduction
Comparison made 
to baseline
Cataract group (n=16) 15.7±2.8 13.4±2.7 (13) P=0.009*, 95% CI 
0.6 to 3.8
14.4±2.6 (7) P=0.005*, 95% CI 
0.17 to 2.6
13.7±2.9 (12) P=0.006*, 95% CI 
0.6 to 3.2
POAG group (n=11) 16.3±4.8 14.5±3.2 (6) P=0.1, 95% CI 
−0.7 to 4.2
14.0±3.6 (9) P=0.1, 95% CI 
−0.8 to 5.1
14.2±3.7 (8) P=0.2, 95% CI 
−1.3 to 5.5
Overall (n=27) 15.9±3.66 13.9±2.9 (12) P=0.003*, 95% CI 
0.7 to 3.3
14.3±3.0 (10) P=0.02*, 95% CI 0.3 
to 2.9
13.9±3.2 (10) P=0.008*, 
95% CI 0.5 to 3.4
Additionally, percentage of IOP reduction is shown.
*Statistically significant.
IOP, intraocular pressure; POAG, primary open angle glaucoma.
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with higher preoperative IOP7; this may explain the greater IOP 
reduction in the OHTS group.
A recent randomised control trial of a Schlemm’s canal 
microstent (Hydrus II) with phacoemulsification in patients 
with open angle glaucoma, assessed 100 patients.7 Cases were 
randomised to have either CS alone or CS with microstent 
implant. In the CS group, washed-out IOP reduced from 
baseline of 26.6±4.2 to 17.4±3.7 mm Hg at 12 months. The 
mean IOP reduction was 9.0 mm Hg at 1 year. This study had 
much higher baseline IOP (26.6±4.2 mm Hg) and conse-
quently, greater observed IOP reduction (9.0 mm Hg) at 
1 year, compared with our study (2.0±3.6 mm Hg) and OHTS 
(4.0 mm Hg).20 One should take into consideration the effect 
of regression to the mean phenomenon when interpreting a 
physiological values such as IOP which is known to fluctuate.7
Contrary to our study, Meyer and associates10 reported 
no enhancement of the facility of outflow at 6 weeks’ post 
phacoemulsification CS (baseline outflow facility of 0.39±0.23 
vs 0.37±0.16 µL/min mm Hg 6 weeks). This may partly be 
attributable to the inconsistency of pneumatonography tech-
nique used in their study, highlighted by their much higher 
than usual baseline outflow facility value compared with other 
historical data.21
Kee and Moon22 carried out pneumatonography before 
and 2 months after phacoemulsification with IOL implan-
tation in 42 patients with cataract. In this study, the IOP 
reduction was 2.4±0.4 mm Hg at 2 month postoperatively. 
They demonstrated that outflow facility improved from 
0.26±0.01 to 0.30±0.01 µL/min mm Hg 2 months after lens 
extraction. Although the duration of that study was short, 
their findings are in agreement with our results at 3 months 
(0.14±0.07 preoperatively vs 0.18±0.09 µL/min mm Hg at 3 
months). It is worth pointing out that the latter study did not 
report the anterior chamber depth or gonioscopy of their cases 
prior to the CS. One would assume that considering the higher 
prevalence of angle closure in Korean population, narrow 
angle cases might have been included in their study inadver-
tently, making the effect of the lens removal on IOP reduction 
and the facility of outflow more exaggerated.
TOF encompasses changes in trabecular outflow facility, as 
well as any pressure-dependent changes to inflow (pseudofa-
cility) or uveoscleral outflow.23 24 Nonetheless, in our study, 
we investigated the change in TOF before and after CS using 
the same measurement technique, which theoretically means 
that these potential confounding effects should be less of an 
issue.
Figure 1 Overall intraocular pressure (IOP) changes on each time 
point postoperatively compared with baseline IOP. *Statistically 
significant.
Table 3 This shows TOF enhancement postsurgery at each postoperative visit at 3, 6 and 12 months compared with baseline TOF
TOF at 
baseline
TOF at 3 m (µL/
min mm Hg), % of 
enhancement
Comparison made 
to baseline
TOF at 6 m (µL/
min mm Hg), % of 
enhancement
Comparison made 
to baseline
TOF at 12 (µL/
min mm Hg), % of 
enhancement
Comparison made 
to baseline
Cataract group (n=16) 0.15±0.06 0.20±0.09 (15) P=0.05, 95% CI 
−0.11 to 0.1
0.22±0.10 (17) P=0.02*, 95% CI 
−0.12 to  −0.01
0.18±0.07 (10) P=0.25, 95% CI 
−0.07 to 0.02
POAG group (n=11) 0.13±0.08 0.15±0.06 (14) P=0.2, 95% CI 
−0.07 to 0.01
0.17±0.07 (16) P=0.05*, 95% CI 
−0.08 to  −0.1
0.17±0.08 (15) P=0.07, 95% CI 
−0.09 to 0.006
Overall (n=27) 0.14±0.06 0.18±0.08 (16) P=0.02*, 95% CI 
−0.07 to  −0.007
0.20±0.09 (15) P=0.003*, 95% CI 
−0.09  to  −0.02
0.17±0.08 (10) P=0.04*, 95% CI 
−0.06  to  −0.001
Additionally, the percentage of TOF enhancement is shown. 
*Statistically significant.
IOP, intraocular pressure; POAG, primary open angle glaucoma; TOF, tonographic outflow facility.
Figure 2 Overall tonographic outflow facility changes at each 
postoperative visit compared with baseline intraocular pressure. 
*Statistically significant.
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Although the most widely held view regarding the mechanism of 
IOP-lowering effect postphacoemulsification is through increased 
trabecular outflow facility, there were some speculations as to 
whether phacoemulsification may affect uveoscleral outflow as 
well as other aqueous humour dynamic parameters.2 In order to 
explore this, we made some calculations using the Goldmann’s 
equation (see online Supplementary appendix). If we assume that 
other aspects of aqueous dynamic parameters, such as aqueous 
production  (Ff), uveoscleral outflow  (Fu) or episcleral venous 
pressure  (Pe) are unlikely to be affected by phacoemulsification 
and the mechanism of IOP-lowering effect of phacoemulsification 
CS is solely via the increase in trabecular outflow facility, then 
according to Goldmann’s equation, a 10%–12% reduction in IOP 
(Pi) at all postoperative visits seen in our study should correspond 
to 11%–18% increase in TOF (C) and this correlated well with our 
measured increase of 10%–15% in TOF. As this largely accounts 
for the amount of IOP reduction, one can therefore conclude that 
the reason for the IOP drop postphacoemulsification is caused by 
an increase in trabecular outflow facility rather than any effects 
on other aqueous dynamic parameters such as uveoscleral outflow 
(see online Supplementary appendix).
In our study, there was no linear correlation between AXL, 
IOP and TOF. The available evidence generally corroborates our 
findings with regard to AXL and IOP.25–27 However, there are no 
previous studies looking at the relationship between TOF and 
AXL.
However, the question remains as to the underlying mech-
anism for the increase in trabecular outflow facility. Both 
mechanical changes and modifications at the cellular level 
have been put forward as the potential reason for the increase 
in outflow facility postphacoemulsification.4 28–31 Although 
this is outside the scope of this study, it is useful to describe 
these theories briefly.
Based on the mechanical theory, the anterior chamber biometric 
alterations after phacoemulsification as well as other changes,30 31 
may have been responsible for the increase in trabecular outflow 
facility.4 Zhao et al exhibited a significant expansion of the 
Schlemm’s canal based on optical coherent scans in eyes that had 
undergone phacoemulsification. Mehdizadeh also contemplated 
that the changes in the contractility of the ciliary muscles may have 
been accounted for the increase in trabecular outflow facility and 
the subsequent drop in IOP.30
Figure 3 Intraocular pressure changes over 12 months’ period 
compared between each visit. *Statistically significant.
Figure 4 Correlation between tonographic outflow facility (TOF) 
changes and intraocular pressure (IOP) alterations at all time point. 
There is no linear correlation (P=0.08, r2=0.1).
Figure 5 Demonstrates facility of outflow alteration during 12-month 
period in each group of patients separately. *Statistically significant.
Figure 6 Correlation between baseline tonographic outflow facility 
(TOF) and 3 months after surgery TOF.
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Per the cellular theory, proposed by Wang et al28 and Tsuboi 
et al,29 ultrasound can induce chemical and cellular changes in 
vitro in cultured trabecular meshwork cells. However, another 
in vivo clinical studies failed to show a linear correlation 
between ultrasound energy and IOP reduction after CS.32
One limitation of our study is that POAG cases should have had 
a washout period from their glaucoma medications prior to study 
measurements. However, the number of medications which can 
affect trabecular outflow facility remained unchanged postopera-
tively. Furthermore, the results of the subgroup analysis were also 
similar to that of the combined data. However, because the number 
of subgroup cases were small, the subgroup analysis should be 
interpreted with caution.
To our knowledge, this is the first study to assess the TOF 
after small incision phacoemulsification cataract extraction 
and IOL implantation using electronic Schiotz tonographer, 
which is the least variable measurement technique compared 
with other techniques, with documented anterior chamber 
depth and gonioscopy. We demonstrated that the IOP drop 
is accounted for by the increase in TOF. However, the exact 
mechanism of the outflow facility enhancement remains 
unclear from this study. Further research is needed to elicit 
this important question.
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